Update on Mounjaro Prescriptions
You may have seen recent news that GPs are now able to prescribe a new medication called Mounjaro® (Tirzepatide) to support weight management. While this is correct, we would like to clarify the current situation and eligibility requirements, as set out by Cheshire and Merseyside Integrated Care Board (ICB).
Access to Mounjaro® is being rolled out in phases, and at this stage it is only available to a very specific group of patients who meet strict national criteria.
At present it hasn’t been decided who will do the prescribing and we are therefore unable to prescribe Mounjaro at Middlewood at this time. We will update when this changes, and we please ask that patients do not contact the Practice to ask if they are eligible.
Who will be eligible when a decision is made?
To be considered for treatment with Mounjaro®, patients must:
-
- Have a Body Mass Index (BMI) of 40 kg/m² or more,
or 37.5 kg/m² or more if from a minority ethnic background,
- Have a Body Mass Index (BMI) of 40 kg/m² or more,
and
-
- Have at least four of the following long-term health conditions:
- Type 2 diabetes
- Hypertension (high blood pressure)
- Dyslipidaemia
- Established cardiovascular disease
- Obstructive sleep apnoea
- Have at least four of the following long-term health conditions:
We understand that many people may have questions about this medication. You can find more detailed information and answers to frequently asked questions on the Cheshire and Merseyside ICB website: https://www.cheshireandmerseyside.nhs.uk/your-health/prescribing/statements/mounjaro-tirzepatide/
We appreciate your understanding as we follow these guidelines to ensure fair and appropriate access to this treatment.